Barcelona, Spain, will host from 16 to 19 November 2017, the 9th European Multidisciplinary Meeting on Urological Cancers (EMUC17), one of Europe’s well-attended international conferences for multidisciplinary specialists with expertise in urological malignancies.
EMUC17 pursues the goals of earlier editions where critical insights on current and prospective treatment strategies will be discussed by leading experts and opinion leaders with special focus on best practices, achieving consensus on controversial issues and applying the outcomes of translational research.
Organisers of the EMUC draw from the collaborative efforts and resources of the European Society for Medical Oncology (ESMO), the European SocieTy for Radiotherapy & Oncology (ESTRO) and the European Association of Urology (EAU). The collaboration not only offers an annual platform for scientific discussions that address emerging trends in urological cancers, but also links up various specialists and stakeholders in their common aim to achieve quality healthcare.
Affiliated organisations such as the European School of Urology (ESU) with ESU courses on Renal and Bladder Cancer and the EAU Section of Urological Imaging (ESUI) provide vital support to the event and widen the coverage of the Scientific Programme. Additionally, the EAU Prostate Cancer Centre Consesus Meeting (EPCCCM) will be held to define the criteria for a European Prostate Cancer Centre.
From identifying forward-thinking approaches, discussing gaps in current treatment to improving standard medical protocols, the EMUC strives to achieve efficient multidisciplinary collaboration. After nearly a decade, participants of previous EMUC events have lauded EMUC’s role in anticipating key developments which enable cancer experts to tackle future challenges.
Sharing is caring!